ClickMedix provides a guided patient journey platform to help patients navigate the healthcare system and improve health outcomes. The platform uses a health scorecard to assess patients' conditions across multiple areas and provide personalized care plans and referrals. It aims to coordinate care both virtually through mobile apps and in person through care coordinators. This coordinated longitudinal approach could enhance the patient experience, increase treatment adherence, and demonstrate a return on investment through reduced costs and improved health metrics.
Mangalore Call Girls đ 6297143586 đ Genuine WhatsApp Number for Real Meet
Â
Insurance Patient Health Coordination ClickMedix 2015
1. ClickMedix
Right care, at the right time, to improve population
health outcomes while lowering costs.
Ting Shih - Founder & CEO (ting@clickmedix.com)
Ms Jodi Lyons â Healthcare Advisor
Dr Andrew Pumerantz â Medical Advisor
http://clickmedix.com
2. Problem: Patients donât know how to navigate the complex
healthcare system â when to get what care and why
Health Complications
Pharmacy
Gym /
Wellness
Programs
Nutrition
Psychiatrist
3. Currently: Longitudinal Healthcare Tools Are
Insufficient Across Fragmented Services
Patients have to navigate care pathways
across multiple providers and health services
in multiple geographic sites and a variety of
health record charting (electronic and paper)
Average patient with multimorbidity has 11
providers
Fax is the predominant method of referring
patients amongst providers
In the ideal world, navigating the healthcare system to find the right care
should be as easy as navigating with a GPS
4. How it Works: Guided Patient Journey
Discovery
I donât feel well
Easy to Understand
At-a-glance health status
and guided pathway to get
better
Increase Adherence
Guidance and support
through treatment plan
See Results
Measure Impact
Patient perspective
Company perspective
Physician perspective
Self assessment or facilitated
5. 1
<7.0
(<53
mmol/mol)
SBP < 130
DBP < 80
<100 or <70
with CVD
No
Symptoms
& No
Structural
Heart
Disease
At risk;
chronic
cough,
sputum
production;
normal
spirometry
No
Nephropath
y
No
Retinopathy
No Dental
Infection
No
Neuropathy
&
No PAD
18.5-24.9
No
Depressio
n
PHQ-9
score 0
2 7.0-7.9
(53-63
mmol/mol)
SBP 130-
139
DBP < 90
101-130
No
Symptoms
&
+Structural
Heart
Disease
GOLD 1 or 2
& 0-1
exacerbation
s/yr &
mMRC 0-1 &
CAT<10
Albuminuri
a
30-299 mg/g
Non-
Proliferative
Mild
Mild
Gingival
Inflammatio
n
Neuropathy 25-29.9
Minimal
Depressio
n
PHQ-9
score 1-4
3
8.0-8.9
(64-74
mmol/mol)
SBP 140-
149
DBP < 90
131-160
Symptomati
c
&
+ Structural
Heart
Disease
GOLD 1 or 2
& 0-1
exacerbation
s/yr &
mMRC â„2 &
CATâ„10
Albuminuri
a
300-999
or
eGFR 30-
60
Non-
Proliferative
Moderate
Moderate
Gingival
Inflammatio
n
+PAD
&
+/-
Neuropathy
30-34.9
Mild
Depressio
n
PHQ-9
score 5-9
4
9.0-9.9
(75-85
mmol/mol)
SBP <150
DBP 90-99
161-190
Symptomati
c
w/
Heart
Failure
GOLD 3 or 4
& â„2
exacerbation
s/yr &
mMRC 0-1 &
CAT<10
Albuminuri
a
1000-2999
or
eGFR 15-29
Non-
Proliferative
Severe/
Inactive
Proliferative
Severe
Gingival
Inflammatio
n
+ Ulcer
History
35-39.9
Moderate
Depressio
n
PHQ-9
score 10-
14
5 > 10.0
(â„86
mmol/mol)
SBP > 150
-or-
DBP > 100
>191
Refractor
y Heart
Failure
GOLD 3 or 4
& â„2
exacerbation
s/yr &
mMRC â„2 &
CATâ„10
Albuminuri
a
>3,000
or
eGFR â€15
Active
Proliferative
Acute
Dental
Infection
Previous
Amputation
â„40 or
<18.5
Severe
Depressio
n
PHQ-9
score â„15
ï
ï
Patient Receives Health Score Card, along with Care
Plans and Service Referrals
BMI
6. 1
<7.0
(<53
mmol/mol)
SBP < 130
DBP < 80
<100 or <70
with CVD
No
Symptoms
& No
Structural
Heart
Disease
At risk;
chronic
cough,
sputum
production;
normal
spirometry
No
Nephropath
y
No
Retinopathy
No Dental
Infection
No
Neuropathy
&
No PAD
18.5-24.9
No
Depressio
n
PHQ-9
score 0
2 7.0-7.9
(53-63
mmol/mol)
SBP 130-
139
DBP < 90
101-130
No
Symptoms
&
+Structural
Heart
Disease
GOLD 1 or 2
& 0-1
exacerbation
s/yr &
mMRC 0-1 &
CAT<10
Albuminuri
a
30-299 mg/g
Non-
Proliferative
Mild
Mild
Gingival
Inflammatio
n
Neuropathy 25-29.9
Minimal
Depressio
n
PHQ-9
score 1-4
3
8.0-8.9
(64-74
mmol/mol)
SBP 140-
149
DBP < 90
131-160
Symptomati
c
&
+ Structural
Heart
Disease
GOLD 1 or 2
& 0-1
exacerbation
s/yr &
mMRC â„2 &
CATâ„10
Albuminuri
a
300-999
or
eGFR 30-
60
Non-
Proliferative
Moderate
Moderate
Gingival
Inflammatio
n
+PAD
&
+/-
Neuropathy
30-34.9
Mild
Depressio
n
PHQ-9
score 5-9
4
9.0-9.9
(75-85
mmol/mol)
SBP <150
DBP 90-99
161-190
Symptomati
c
w/
Heart
Failure
GOLD 3 or 4
& â„2
exacerbation
s/yr &
mMRC 0-1 &
CAT<10
Albuminuri
a
1000-2999
or
eGFR 15-29
Non-
Proliferative
Severe/
Inactive
Proliferative
Severe
Gingival
Inflammatio
n
+ Ulcer
History
35-39.9
Moderate
Depressio
n
PHQ-9
score 10-
14
5 > 10.0
(â„86
mmol/mol)
SBP > 150
-or-
DBP > 100
>191
Refractor
y Heart
Failure
GOLD 3 or 4
& â„2
exacerbation
s/yr &
mMRC â„2 &
CATâ„10
Albuminuri
a
>3,000
or
eGFR â€15
Active
Proliferative
Acute
Dental
Infection
Previous
Amputation
â„40 or
<18.5
Severe
Depressio
n
PHQ-9
score â„15
ï
ï
Patient Follows a Care Plan and Improves Their Health
Metrics and Score Card
BMI
8. Collaboration with Insurers
âą Enhance patient experience
o Single-point of contact to guide patient through care (via technology
or coordinator)
o Increase treatment adherence
o Increase ability to self-manage
o Provide longitudinal healthcare data to improve health outcomes
âą Demonstrate ROI
o Increased workforce productivity
o Decrease use of unnecessary ER visits
o Correlate payments to patient outcomes